Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
A short time to buy more before the BIG money rolls in. Next Wednesday we will have fulfilled the 5 day above $3.00 rule (Monday is a Holiday). Then it's 5-10 business days before the BIG uplisting to Nasdaq.
Oh man I loved that toottall and yes the Tuba lent in it's charms. Very appropriate I might add.lol
And I for one am going to keep owning this beauty. Go AVXLD
Leo said: "For instance, in this past week, Cellceutix filed an Orphan Drug application with the U.S. Food and Drug Administration (FDA) for Kevetrin for pancreatic cancer". That's more great news as pancreatic cancer was one of the target cancers where Dana Farber saw tumor response. In June 20, 2011 PR it was reported that "Kevetrin™, has demonstrated potent anti-tumor activity in the treatment of a pancreatic carcinoma cell line in a xenograft tumor model. After three weeks of studies, results testing Kevetrin against Pancreatic Carcinoma Cell line MIA-PaCa-2 showed average tumor volume shrinkage of 67% and a tumor growth delay of greater than 94% with no significant weight loss in the animals".
So uplisted and trading the big board on or around October 20??
I wouldn't say good luck to a basher.
That is the icing on the frosting.
According to todays news Missling said " “This reverse stock split will help us meet the conditions to finalize our application for uplisting to NASDAQ.” So it sounds like reverse split is the last leg to uplisting.
Yes P2a data good. Nasdaq uplisting will allow big money buyers to pour in. CNBC and FOX Biz will be all over this one.
As posted earlier it's the herd mentality. Hit article comes out, price turns down and new weak hands sell.. it's a vicious cycle. Longs will still be invested for next Missling epic update.
Nice work BK. Seems we both see the same value. The many longs here also see the value.
Five clinical trials is the value.
1 Completed Bioequivalence and Pharmacokinetic Study of Prurisol™ and Abacavir Sulfate in Healthy Volunteers
Condition: Psoriasis
Interventions: Drug: Prurisol; Drug: Ziagen
2 Recruiting A Safety, Pharmacokinetic and Pharmacodynamic Study of Kevetrin in Patients With Advanced Solid Tumors
Condition: Solid Tumors
Intervention: Drug: thioureidobutyronitrile
3 Recruiting Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis
Condition: Plaque Psoriasis
Interventions: Drug: Prurisol; Drug: Placebo
4 Recruiting Phase 2 Study to Evaluate the Safety & Efficacy of Brilacidin Oral Rinse in Patients With Head and Neck Cancer
Conditions: Head and Neck Neoplasms; Mucositis; Stomatitis; Mouth Diseases
Intervention: Drug: Brilacidin
5 Completed Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections
Conditions: Skin Infection; Bacterial Infection
Interventions: Drug: Daptomycin; Drug: Brilacidin
Five clinical trials is the value.
Nice price action today. Dr Missling is the man. Many Thanks.
To be honest cancer trials are a slow and tedious process. PMCB has passed the Safety trials which is a hurdle in itself. The company is doing what is nessesary to get phase2 up and running. Hoping the best for the company.
Just to be clear to the board I first invested here in 2012 now that were farther along ie labs/safety and now planning phase2 I plan to reinvest. Many thanks to Pistol Pete and others for answering any of my questions and Good luck to all.
I'm a watcher here but I got to tell you the mincing of words is a red flag.
"PMCB who is in the middle of start 3 clinical trials"
Do tell. Good luck with that.
I think the board got a special glimpse of a very positive trial. sept.29 pdf.
9.45 am OC49 - New Exploratory Alzheimer’s Drug ANAVEX 2-73: Clinical Cognitive Improvement observed in
Mini Mental State Examination (MMSE) and other Cognitive Markers in a Phase 2a Study in mild-tomoderate
Alzheimer’s Patients
Updated pdf: Saturday November 7,
9.45 am OC49 - New Exploratory Alzheimer’s Drug ANAVEX 2-73: Assessment of Safety and Cognitive
Performance in a Phase 2a Study in mild-to-moderate Alzheimer’s Patients
Steve Macfarlane, MD (1), Paul Maruff, PhD (2), Marco Cecchi, PhD (3), Dennis Moore, PhD (3), Anastasios
Zografidis, PhD (4), Christopher Missling, PhD (4)
(1) Caulfield Hospital, Melbourne, Australia; (2) Cogstate, Melbourne, Australia; (3) Neuronetrix, KY, USA; (4) Anavex Life Sciences, Corp., New York, NY, USA
http://www.ctad-alzheimer.com/sites/ctad.prod/files/files/PROGRAMprel_CTAD2015_1oct%20(1).pdf pg18
The whole rant was pretty negative against our investment.
PMCB needs IND approved before trial can start. Still checking.
When was application for FDA Fast Track submitted?
The war on bacteria has become a national crisis and the government is responding by kick starting a new antibacterial era with incentive money. The market is still free with much needed safeguards in place.
Sure looks like good news to me.
OC49 - New Exploratory Alzheimer’s Drug ANAVEX 2-73: Clinical Cognitive Improvement observed in Mini Mental State Examination (MMSE) and other Cognitive Markers in a Phase 2a Study in mild-to- moderate Alzheimer’s Patients.
I would like too second that. This is a huge positive update, thank you very much.
Most importantly to me is as far as I can tell Leo has worked hard and has done nothing nefarious to enrich himself while managing this company. His management missteps which have been discussed extensively here has given way for well orchestrated bastards to prey on the low DD, weak hand investors. IMO There are hundreds of late comers selling at a loss out of fear who will stumble back on this stock in a couple months and say " Damn I wish I hadn't sold that one".
"We saw the details in P300 biomarker results released in July. We could expect those results mirrored for up-to 32 patients as topline data"
July22 PR: ANAVEX 2-73 showed in 83 percent (10/12) of patients positive cognitive effects during PART A of the study.
Possibly those 2 patients are now seeing positive cognative effects after further dosage?
Lesson learned.
Due to low interest rates, Billions in savings was flushed down the toilet. Undue fear placed in the market the "Hilary effect".
Looking for: B-OM enrollment update. Kevetrin phase 1 update including finished enrollment. Phase 3 ABSSSI start date. Prurisol ahead of schedule...topline data update. Plenty of arrows in the quiver to boost share price.
And not deja vu all over again...One of my favorites.
Exactly. Leo has many irons in the fire. Partnerhip would ensure capital for trials and lab studies. Partnership would give share price the big lift to uplisting.
Thank You for reply KarinCA. Yes I see Leo expects two trials to run $12mm ($6mm each). I'm guessing trials would run both 2016 and 2017 budget cycles.
Further data showing A-273 results of improved cognitive thinking will be the gold standard.
I would think that the large trial requirement for a B-ABSSSI phase3 would be costly and require a partnership to prove capital availability as part of trial design. A hint might of been when Leo mentioned the design may be global. All just a guess.
This stock is showing strength even after that hellacious gut punch.
According to the PR, Orphan drug application was applied for in October 2014. FDA would have already given an answer. It's either yes or no based on patient treatment population of 200,000 or less.
Yes, I believe the PR was not posted on yahoo until 4pm or shortly after. Looking for buyer interest tomorrow. We will see. Thanks a lot.
This is also posted on yahoo. Just another ambulance chaser hitching to the original complaint.
Not sure what time this was posted on yahoo, never saw it this morning.
Christopher U. Missling, PhD, President and Chief Executive Officer, will present at the Ladenburg Thalmann 2015 Healthcare Conference on Tuesday, September 29, 4:00pm.
It says Missling will "present".. Possible Data update soon??
http://finance.yahoo.com/news/anavex-present-2015-ladenburg-thalmann-110000609.html
I'm loaded and holding .40-.80. Next data release could be epic. Good luck.